Literature DB >> 12228255

X-ray structure of two crystalline forms of a streptomycete ribonuclease with cytotoxic activity.

Jozef Sevcik1, Lubica Urbanikova, Peter A Leland, Ronald T Raines.   

Abstract

Ribonuclease (RNase) Sa3 is secreted by the Gram-positive bacterium Streptomyces aureofaciens. The enzyme catalyzes the cleavage of RNA on the 3' side of guanosine residues. Here, x-ray diffraction analysis was used to determine the three-dimensional structure of two distinct crystalline forms of RNase Sa3 to a resolution of 2.0 and 1.7 A. These two structures are similar to each other as well as to that of a homolog, RNase Sa. All of the key active-site residues of RNase Sa (Asn(42), Glu(44), Glu(57), Arg(72), and His(88)) are located in the putative active site of RNase Sa3. Also herein, RNase Sa3 is shown to be toxic to human erythroleukemia cells in culture. Like onconase, which is an amphibian ribonuclease in Phase III clinical trials as a cancer chemotherapeutic, RNase Sa3 is not inhibited by the cytosolic ribonuclease inhibitor protein. Thus, a prokaryotic ribonuclease can be toxic to mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228255     DOI: 10.1074/jbc.M208425200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Antitumor RNases: killer's secrets.

Authors:  Vladimir A Mitkevich; Olga N Ilinskaya; Alexander A Makarov
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Microbial ribonucleases (RNases): production and application potential.

Authors:  E Esin Hameş; Tuğçe Demir
Journal:  World J Microbiol Biotechnol       Date:  2015-10-03       Impact factor: 3.312

3.  Increased alkalotolerant and thermostable ribonuclease (RNase) production from alkaliphilic Streptomyces sp. M49-1 by optimizing the growth conditions using response surface methodology.

Authors:  Tuğçe Demir; Özkan Gübe; Mesut Yücel; E Esin Hameş-Kocabaş
Journal:  World J Microbiol Biotechnol       Date:  2013-03-27       Impact factor: 3.312

Review 4.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

5.  Function inferences from a molecular structural model of bacterial ParE toxin.

Authors:  Luiz Carlos Bertucci Barbosa; Saulo Santesso Garrido; Anderson Garcia; Davi Barbosa Delfino; Reinaldo Marchetto
Journal:  Bioinformation       Date:  2010-04-30

6.  Increasing protein stability by improving beta-turns.

Authors:  Hailong Fu; Gerald R Grimsley; Abbas Razvi; J Martin Scholtz; C Nick Pace
Journal:  Proteins       Date:  2009-11-15

7.  Contribution of single tryptophan residues to the fluorescence and stability of ribonuclease Sa.

Authors:  Roy W Alston; Lubica Urbanikova; Jozef Sevcik; Mauricio Lasagna; Gregory D Reinhart; J Martin Scholtz; C Nick Pace
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

Review 8.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

9.  Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.

Authors:  Nadezhda L Mironova; Irina Y Petrushanko; Olga A Patutina; Aexandra V Sen'kova; Olga V Simonenko; Vladimir A Mitkevich; Oleg V Markov; Marina A Zenkova; Alexander A Makarov
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

10.  A type II secreted RNase of Legionella pneumophila facilitates optimal intracellular infection of Hartmannella vermiformis.

Authors:  Ombeline Rossier; Jenny Dao; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.